Physician profile
David Cullinane
NPI 1770589236
$156.66
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2021: $33.40.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $56.92 | 2019 | |
| Medtronic Vascular, INC. | $25.40 | 2019 | |
| Medtronic, INC. | $21.41 | 2021 | |
| Philips North America LLC | $15.06 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.40 | 2019 | |
| Terumo Medical Corporation | $12.48 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.99 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cullinane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.